Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001562230-25-000090·Ascendis Pharma A/S
Schedule 13G ownership disclosure
ASCENDIS PHARMA A/S
Common Stock · CUSIP: 04351P101
Event date: 2025-06-30
- Filing-level shares
- 3,109,225.00
- Percent of class
- 5.6%
- Capital International Investors
Shares: 3,109,225.00 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-25-000090
- Form type
- SCHEDULE 13G
- Filer
- Ascendis Pharma A/S
- CIK
- CIK 1612042
- Filed
- Aug 13, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership